Cuts proposed by the Trump administration and House Republicans could drive up new HIV cases by more than 200,000 by 2030, ...

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Two partnerships will provide millions of people access to what is widely described as the most effective HIV prevention drug ...

Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

A partnership will enable low-cost, generic lenacapavir for HIV prevention in LMICs, aiming to improve access and reduce ...

The CDC is recommending a groundbreaking drug to help prevent HIV, as advocates urged CVS Health to reverse a recent decision ...

A game-changing HIV prevention drug is set to become vastly more affordable in over 100 low- and middle-income countries, a ...

Indian companies to sell generic HIV prevention drug for $40/year by 2027, aiming to end AIDS crisis globally.

Global health groups will provide backing for two generic manufacturers to produce and distribute a low-cost version of a new ...

Hetero and Dr Reddy’s will be funded by the Gates Foundation and Unitaid to produce and sell the twice-a-year anti-HIV shot ...